Viewing nowNexpa Tablet 40 mg (Esomeprazole Magnesium Trihydrate)
Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.

MFDS item code 201404800 · Approved 2014.10.20 · Insurance code 657805440
Treatment of acid-related disorders (reflux and Zollinger-Ellison syndrome), ulcers and Helicobacter pylori infection, and gastrointestinal disorders caused by anti-inflammatory drugs
This medication is used for the treatment of gastroesophageal reflux disease and erosive esophagitis, effective for long-term maintenance therapy to prevent recurrence in patients with esophagitis and for treating symptoms of gastroesophageal reflux disease without esophagitis. It is also used for the treatment of duodenal ulcers and peptic ulcers associated with Helicobacter pylori infection, as well as for the prevention of recurrence. Additionally, it helps relieve upper gastrointestinal symptoms that may arise during the use of non-steroidal anti-inflammatory drugs and treats gastric ulcers in patients requiring ongoing therapy with non-steroidal anti-inflammatory drugs, as well as preventing gastric ulcers and duodenal ulcers. It is also used for the treatment of Zollinger-Ellison syndrome and maintenance therapy after prevention of rebleeding caused by gastric ulcer or duodenal ulcer. Therefore, it is effective in improving various gastrointestinal diseases and associated symptoms.
1. Adults 1) Gastroesophageal reflux disease (GERD). - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist should take the medicine for an additional 4 weeks. - Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once daily - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. · Once symptoms have resolved, subsequent recurrent symptoms are controlled by administering 20 mg once daily. · In adults, 20 mg may be administered once daily as needed. For patients at high risk of developing gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drug treatment, as-needed administration is not recommended to control recurring symptoms. 2) Combination therapy with antibiotics for Helicobacter pylori eradication Administer this medicine 20 mg in combination with amoxicillin 1 g and clarithromycin 500 mg, twice daily for 7 days. 3) Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, burning sensation) associated with use of nonsteroidal anti-inflammatory drugs (nonselective or selective COX-2 inhibitors) - 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. Clinical trials longer than 4 weeks have not been conducted. 4) Patients requiring continued nonsteroidal anti-inflammatory drug treatment - Treatment of gastric ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. The treatment period is 4∼8 weeks. - Prevention of gastric and duodenal ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. 5) Treatment of Zollinger-Ellison syndrome The recommended initial dose is 40 mg twice daily. The subsequent dose should be adjusted for each patient, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg per day. Doses exceeding 80 mg per day should be divided into 2 doses. 6) Maintenance therapy following induction of prevention of rebleeding due to gastric or duodenal ulcers by intravenous injection Administer 40 mg once daily for 4 weeks following induction of prevention of rebleeding due to gastric or duodenal ulcers by intravenous injection. 4. Renal impairment: No dose adjustment is necessary. Use with caution because there is limited experience administering this medicine to patients with severe renal impairment. 5. Hepatic impairment: No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, the dose of this medicine should not exceed 20 mg. 6. Older adults: No dose adjustment is necessary.
2. Adolescents aged 12 years or older 1) Gastroesophageal reflux disease (GERD) - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist should take the medicine for an additional 4 weeks. - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. · Once symptoms have resolved, subsequent recurrent symptoms are controlled by administering 20 mg once daily. · In adults, 20 mg may be administered once daily as needed. For patients at high risk of developing gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drug treatment, as-needed administration is not recommended to control recurring symptoms. 3. Children under 12 years of age: There is no experience with administering this medicine to children under 12 years of age.
This medication should not be administered to specific patients. Avoid use if there is an allergy to this medication or its components, or if there is a hypersensitivity to certain antibiotics. Also, patients taking certain heart-related medications or with a history of myocardial infarction, as well as nursing mothers, should not take this medication. Various side effects may occur with this medication. Common gastrointestinal symptoms include headache, abdominal pain, diarrhea, nausea, and vomiting; rarer symptoms may include blood abnormalities, skin rashes, and liver function abnormalities. Occasionally, mental instability, dizziness, and blurred vision may also occur, so caution is needed. If this medication is used for a long period, regular health checks should be conducted, particularly if taken for over one year, including blood tests for magnesium levels. This medication may suppress gastric acid secretion and increase the risk of gastrointestinal bacterial infections, so if diarrhea persists, immediate consultation with a healthcare provider is necessary. This medication can interact with other drugs, so if taking other medications, it is essential to inform your physician or pharmacist. Caution is especially needed when taking with medications affecting blood coagulation, antiviral drugs, or certain antibiotics. Women who are pregnant or nursing should consult a physician before taking this medication, as its safety has not been sufficiently confirmed. There is no specific antidote for overdose; treatment should be based on symptoms, and appropriate care should be sought from a hospital if necessary. Keep this medication out of reach of children and do not transfer it to another container.
Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylaxis, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, anxiety, confusion, depression, aggression, hallucinations, headache, dizziness, paresthesia, drowsiness, taste disorders, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal distension, nausea, vomiting, xerostomia, stomatitis, gastrointestinal candidiasis, microscopic colitis, elevated liver enzymes, hepatitis, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, hair loss, photosensitivity, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized pustular psoriasis, eosinophilia with systemic symptoms drug reaction, fracture, arthralgia, myalgia, muscle weakness, interstitial nephritis, gynecomastia, asthenia, increased sweating, Clostridium difficile-associated diarrhea, abdominal bloating, allergic reaction, back pain, chest pain, sternal pain, facial edema, facial flushing, fatigue, fever, influenza-like illness, generalized edema, leg edema, malaise, pain, rigidity, peripheral edema, flushing, hypertension, tachycardia, goiter, irritable bowel syndrome, exacerbation of constipation, dyspepsia, dysphagia, gastrointestinal dysmotility, epigastric pain, belching, esophageal disorders, frequent bowel movements, gastroenteritis, gastrointestinal bleeding, hiccups, black stools, oral disorders, pharyngeal disorders, rectal disorders, gastrointestinal symptoms, increased serum gastrin, tongue disorders, tongue swelling, ulcerative stomatitis, otalgia, tinnitus, anemia, hypochromic anemia, cervical lymphadenopathy, epistaxis, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, liver dysfunction, increased ALT, increased AST, diabetes, hyperuricemia, increased ALP, dry mouth, vitamin B12 deficiency, weight gain, weight loss, exacerbation of arthritis, arthropathy, seizures, fibromyalgia syndrome, hernia, rheumatic polymyalgia, anorexia, apathy, increased appetite, confusion, worsening depression, muscle hypertonicity, sensory impairment, erectile dysfunction, insomnia, migraine, exacerbation of migraine, sleep disorders, tremor, visual field defect, dysmenorrhea, menstrual disorders, vaginitis, exacerbation of asthma, cough, dyspnea, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, anal itching, erythematous rash, papular rash, otitis media, dysosmia, taste loss, ageusia, abnormal urination, albuminuria, cystitis, dysuria, fungal infection, hematuria, urinary frequency, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyps or nodules, Barrett's esophagus, mucosal discoloration, fracture, myalgia, asthenia, rhabdomyolysis, erythematous lupus, systemic lupus erythematosus, gastric fundic gland polyp, hypocalcemia, hypokalemia, Stevens-Johnson syndrome, toxic epidermal necrolysis, eosinophilia with systemic symptoms drug reaction, acute generalized pustular psoriasis
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent air or moisture from entering, and must be kept at room temperature between 1°C and 30°C. Proper storage helps maintain its effectiveness.
Pink round film-coated tablet
28 tablets (14 tablets/PTP x 2)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowEsomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Dihydrate 43.38mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Esomeprazole Magnesium Dihydrate 21.69mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.